Has Anthony Bradshaw, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,689 in general payments to Anthony Bradshaw, MD across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anthony Bradshaw, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anthony Bradshaw, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anthony Bradshaw, MD

Internal Medicine · Houston, TXNPI 1932593381

Payments from drug & device makers

$1,689in general payments, 2019–2025

Across 15 payments — averaging $112.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UCB, Inc.$687
Johnson & Johnson$295
Alnylam Pharmaceuticals Inc.$255
Catalyst Pharmaceuticals, Inc.$188
AstraZeneca$131
Argenx US, Inc.$109
plus $22 from 1 others

What the payments were for

Food & beverage$1,689100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UCB, Inc.	5	$687
Johnson & Johnson	2	$295
Alnylam Pharmaceuticals Inc.	2	$255
Catalyst Pharmaceuticals, Inc.	2	$188
AstraZeneca	2	$131
Argenx US, Inc.	1	$109
Amgen	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,689 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$45,927

Medicare patients

149

Services billed

324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
PrivigenImmun Glob G(Igg)/Pro/Iga 0-50	92	$1,404,838
Gamunex-CImmune Globul G/Gly/Iga Avg 46	49	$556,141
HizentraImmun Glob G(Igg)/Pro/Iga 0-50	28	$517,466
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50	40	$515,472
OctagamImmun Globg(Igg)/Malt/Iga Ov50	34	$480,575
Mycophenolate Mofetil	35	$11,550
Mycophenolic AcidMycophenolate Sodium	26	$8,620
Pyridostigmine Bromide	24	$3,872
Azathioprine	14	$3,443
Gabapentin	106	$2,579
Pregabalin	53	$2,341
Duloxetine Hcl	94	$2,308
Prednisone	95	$830
Primidone	20	$578
Sodium Chloride0.9 % Sodium Chloride	71	$521

Paid to pharmacies, not to this prescriber.

Other internal medicine in Houston

Jan BurgerHouston$47.3M
Nitin JainHouston$33.2M
Aung NaingHouston$30.6M
Preetesh JainHouston$19.5M
Paolo StratiHouston$19.2M
Nicholas ShortHouston$17.6M
Isabella GlitzaHouston$14.8M
Murtaza MussajiHouston$13.1M
Hussein TawbiHouston$12.6M
Hans LeeHouston$11.7M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →